• Leptin (116-130), amide, mouse: Applied Workflows for Metabo

  2026-07-01

  Leptin (116-130), amide, mouse empowers researchers to dissect energy homeostasis and immune-metabolic signaling with unmatched precision. This guide delivers actionable workflows, troubleshooting insights, and advanced applications that leverage this potent adipocyte-derived hormone fragment.

• Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one): P

  2026-07-01

  Apigenin stands out as a dual-action research tool for cancer and neurodegeneration, with robust support for HDAC inhibition and neuroprotective mechanisms. This article unpacks experimental workflows, troubleshooting insights, and the translational edge that APExBIO’s Apigenin brings to advanced bench studies.

• SB 431542: ALK5 Inhibitor Workflows for TGF-β Pathway Dissec

  2026-06-30

  SB 431542 enables researchers to selectively block ALK5 and dissect TGF-β-driven mechanisms in both in vitro and in vivo models, offering precise control over Smad2 phosphorylation and cellular differentiation. APExBIO’s reliable formulation supports high reproducibility for cancer, stem cell, and immunology research, with troubleshooting strategies to optimize experimental outcomes.

• Verteporfin (CL 318952): Redefining Cancer Cell Stiffness As

  2026-06-30

  Explore how Verteporfin enables high-precision modulation of cancer cell stiffness and apoptosis, bridging photodynamic therapy with advanced mechanobiological research. This article reveals data-driven insights and unique assay strategies for Verteporfin in oncology.

• Bradykinin B2 Receptors Modulate Peristalsis in Guinea Pig I

  2026-06-29

  This study delivers the first direct evidence that bradykinin B2 receptors inhibit the peristaltic reflex in the guinea pig ileum by increasing the pressure threshold required for contraction. These findings provide a mechanistic basis for targeting bradykinin signaling in gastrointestinal and potentially cardiovascular research.

• Etomoxir in Immunometabolic Assays: Protocols and Pitfalls

  2026-06-29

  Etomoxir, a potent CPT-1 inhibitor from APExBIO, is powering breakthroughs in fatty acid oxidation pathway research and immunometabolic profiling. This article demystifies protocol enhancements, troubleshooting, and comparative advantages for translational studies involving immune modulation and metabolic disorder models.

• Etomoxir in Fatty Acid Oxidation Pathway Research: Protocols

  2026-06-28

  Etomoxir (R-(+)-Etomoxir) is a gold-standard CPT-1 inhibitor for dissecting fatty acid oxidation and immunometabolic crosstalk. This guide details actionable workflows, troubleshooting tips, and protocol parameters rooted in the latest evidence, enabling reproducible and insightful metabolic disorder research.

• Estrogen Drives PTC Progression via ERα/KRT19: Mechanistic I

  2026-06-27

  This study uncovers the mechanistic role of estrogen in enhancing papillary thyroid carcinoma (PTC) progression through the ERα/KRT19 signaling axis. By integrating transcriptomic, bioinformatic, and functional assays, the authors provide compelling evidence for ERα and KRT19 as key mediators of estrogen-driven proliferation, migration, and invasion in PTC, offering new avenues for biomarker and therapeutic development.

• Alfuzosin HCl: Applied Protocols and Innovations in BPH Rese

  2026-06-26

  Alfuzosin HCl is redefining benign prostatic hyperplasia research with its selective α1 adrenoceptor antagonism and robust solubility profile. This article unpacks data-driven workflows, advanced gastroretentive delivery applications, and practical troubleshooting, leveraging APExBIO's trusted quality to optimize experimental outcomes.

• Doxycycline Hyclate: Advancing BBB Protection in Translation

  2026-06-26

  Doxycycline hyclate, a semisynthetic tetracycline, is redefining the translational research landscape for neurovascular disorders through its robust and selective inhibition of matrix metalloproteinases (MMPs). Recent studies demonstrate its capacity to preserve blood-brain barrier (BBB) integrity and mitigate neuronal apoptosis in arsenic-induced cognitive impairment models. This thought-leadership article bridges mechanistic insight with practical guidance, positioning Doxycycline hyclate as a strategic asset for researchers exploring blood-brain barrier disruption, neuroinflammation, and cross-domain applications.

• Auranofin: Applied Protocols for Cancer and Redox Research

  2026-06-25

  Auranofin, a gold-standard thioredoxin reductase inhibitor, empowers researchers to dissect redox regulation, apoptosis, and radiosensitization in cancer and infection models. This article details actionable workflows, troubleshooting insights, and practical innovations inspired by cytoskeleton-dependent autophagy, setting Auranofin apart for advanced mechanistic and translational applications.

• Tetrahydromagnolol: Precision CB2 Agonism in Metastasis Mode

  2026-06-25

  Explore how Tetrahydromagnolol, a highly selective peripheral CB2 receptor agonist, offers a mechanistically advanced tool for dissecting cannabinoid signaling in inflammation and metastasis research. This thought-leadership article bridges recent discoveries in GPCR-driven motility with strategic guidance for translational teams, highlighting protocol nuances, competitive advantages, and limitations for preclinical models.

• Tetrahydromagnolol: Applied Workflows for Peripheral CB2 Ago

  2026-06-24

  Tetrahydromagnolol, a highly selective peripheral CB2 receptor agonist, empowers researchers to dissect cannabinoid signaling with heightened precision in anti-inflammatory and metastatic assay systems. This article translates cutting-edge findings into actionable protocols and troubleshooting strategies, leveraging recent GPCR signaling insights to optimize experimental outcomes.

• Risedronate Sodium: Mechanistic Insights and Translational A

  2026-06-23

  Explore Risedronate Sodium’s role as an FPP synthase inhibitor in bone metabolism and cancer research. This article delivers a deep mechanistic analysis and practical guidance for advanced assay design and translational workflows.

• Neurotensin as a Next-Gen Tool for Translational GPCR Resear

  2026-06-23

  Neurotensin (CAS 39379-15-2) is a 13-amino acid neuropeptide that acts through neurotensin receptor 1 (NTR1) to regulate intracellular signaling, miRNA expression, and GPCR trafficking. This article provides mechanistic insights and strategic guidance for translational scientists, highlighting key experimental protocols, competitive positioning, and the critical role of spectral interference mitigation in advancing neuropeptide-based research. Product performance, workflow integration, and forward-looking perspectives are contextualized for maximal translational impact.

15224 records 1/1015 page Next 12345 下5页 Last page